Bright Uro Announces $23M Series A Funding Round Led by Laborie – Expands Senior Leadership Team to Accelerate Next Phase of Commercialization
Company Names Chief Product Development Officer and Chief Commercial Officer as Glean continues to progress to regulatory clearance IRVINE, Calif.–(BUSINESS WIRE)–Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations... Read More →
FormaPath (formerly Parker Isaac Instruments) Announces Advancement in Cancer Pathology With the Launch of AdiPress
Cutting-edge medical technology company launches the first-ever, automated tool for lymph node dissection to support cancer staging for patients with solid tumors ITHACA, N.Y., Nov. 28, 2023 /PRNewswire/ — Today, FormaPath announced the commercial launch of AdiPress, the first and... Read More →
Savage Medical Exits Stealth With Over $3 Million to Enable Minimally Invasive Colorectal Tumor Removal
SAN FRANCISCO, Nov. 28, 2023 /PRNewswire/ — Savage Medical, Inc. (“SavageMed”, “Company”, “We”, or “Us”), a San Francisco Bay Area-based, clinical-stage medical technology company enabling minimally invasive colorectal tumor removal, today announced a launch out of stealth with over $3... Read More →
Pristine Surgical fully launches single-use arthroscope in the U.S.
Pristine Surgical announced today that it accelerated the launch of its first-of-its-kind Summit 4K single-use surgical arthroscope. Summit combines a 4K single-use surgical arthroscope with the company’s cloud-based software Pristine Connect. The device provides a high-definition image every time. Read... Read More →
Kheiron’s AI Tool Mia Increases Breast Cancer Detection Rate by 13%, Nature Study Reveals
UK-based cancertech company Kheiron has made a significant leap in the fight against breast cancer with their AI tool, Mia, as evidenced by a recent study published in Nature Medicine. According to the new paper Mia has demonstrated the ability... Read More →
Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
CAMBRDIGE, Mass. and SECAUCUS, N.J., Nov. 20, 2023 /PRNewswire/ — Universal DX (“UDX”), a biotech company on a mission to transform cancer into a curable disease, today announced a strategic collaboration with Quest Diagnostics (“Quest”) (NYSE: DGX), the nation’s leading... Read More →
Innovative Research, Inclusive Trials, and New Funding Drives Hope for People with Parkinson’s Disease featuring PhotoPharmics
PhotoPharmics Secures $16 Million Investment Led by Kickstart to Fund Pivotal Clinical Trial for FDA Market Authorization This investment is a pivotal moment in our journey to transform the treatment landscape for Parkinson’s disease.”— Kent Savage, CEO AMERICAN FORK, UT,... Read More →
Koya Medical Raises New Capital with OrbiMed to Support Growth
OAKLAND, Calif. and NEW YORK, Nov. 15, 2023 /PRNewswire/ — OrbiMed, a leading healthcare investment firm and Koya Medical, a healthcare company with a mission to transform venous and lymphatic treatments through novel, people-centric solutions, today announced the closing of... Read More →
Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics
OXFORD, England and BOSTON, Nov. 14, 2023 /PRNewswire/ — Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, and Day Zero Diagnostics (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI... Read More →